Showing 1 - 5 results of 5 for search 'Tessier, J', query time: 0.02s
Refine Results
-
1
-
2
-
3
Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials. by Kraeber-Bodéré, F, Carlier, T, Naegelen, V, Shochat, E, Lumbroso, J, Trampal, C, Nagarajah, J, Chua, S, Hugonnet, F, Stokkel, M, Gleeson, F, Tessier, J
Published 2012Journal article -
4
Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors. by Leijen, S, Middleton, MR, Tresca, P, Kraeber-Bodéré, F, Dieras, V, Scheulen, M, Gupta, A, Lopez-Valverde, V, Xu, Z, Rueger, R, Tessier, J, Shochat, E, Blotner, S, Naegelen, V, Schellens, J, Eberhardt, W
Published 2012Journal article -
5
A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging... by Mitchell, C, O'Connor, J, Roberts, C, Watson, Y, Jackson, A, Cheung, S, Evans, J, Spicer, J, Harris, A, Kelly, C, Rudman, S, Middleton, M, Fielding, A, Tessier, J, Young, H, Parker, G, Jayson, G
Published 2011Journal article